• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     HAYES, Inc. Screening for Lynch syndrome
2014     Basque Office for Health Technology Assessment (OSTEBA) [Retinal protection during eye surgery]
2014     The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and symptoms of depression and burnout]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hepatitis C polymorphism testing: a review of the clinical evidence
2014     NIHR Health Services and Delivery Research programme Testing accelerated experience-based co-design: a qualitative study of using a national archive of patient experience narrative interviews to promote rapid patient-centred service improvement
2014     Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Platelet rich plasma lumbar disc injections for lower back pain: clinical effectiveness, safety, and guidelines
2014     NIHR Health Services and Delivery Research programme The work, workforce, technology and organisational implications of the 111 single point of access telephone number for urgent (non-emergency) care: a mixed-methods case study
2014     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness and efficacy of minimally invasive lung volume reduction surgery for emphysema]
2014     NIHR Health Technology Assessment programme The feasibility of using a parenting programme for the prevention of unintentional home injuries in the under-fives: a cluster randomised controlled trial
2014     The Swedish Council on Health Technology Assessment (SBU) [Dyslexia in children and adolescents – tests and interventions]
2014     NIHR Health Technology Assessment programme Canagliflozin in combination therapy for treating type 2 diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oncotype DX in women and men with ER-positive, HER2-negative early stage breast cancer who are lymph node negative: a review of clinical effectiveness and guidelines
2014     NIHR Health Services and Delivery Research programme Implications for the NHS of inward and outward medical tourism: a policy and economic analysis using literature review and mixed-methods approaches
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) for relapsed chronic lymphocytic leukaemia – in combination with bendamustine and rituximab
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2014     Basque Office for Health Technology Assessment (OSTEBA) [Use of radiography in diagnosing low back pain: systematic review]
2014     The Swedish Council on Health Technology Assessment (SBU) [Chronic ulcers in the elderly – prevention and treatment]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes care for indigenous populations: a review of the clinical evidence and guidelines
2014     NIHR Health Services and Delivery Research programme Variations in outcome and costs among NHS providers for common surgical procedures: econometric analyses of routinely collected data
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for metastatic hormone-relapsed prostate cancer following docetaxel treatment and radiotherapy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines
2014     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2014     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Field evaluation of the initial treatment of STEMI in Quebec's hospitals - phase 2]
2014     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure
2014     NIHR Health Technology Assessment programme Afatinib for treating epidermal growth factor receptor mutation positive locally advanced or metastatic non-small cell lung cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bolused (vice infused) tranexamic acid in adults experiencing hemorrhagic shock: safety, patient benefits, and guidelines
2014     NIHR Health Services and Delivery Research programme The efficient use of the maternity workforce and the implications for safety and quality in maternity care: a population-based, cross-sectional study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lanreotide for unresectable, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014     Basque Office for Health Technology Assessment (OSTEBA) [Pilot study to identify and assess obsolete health technologies from emerging technologies identification databases]
2014     NIHR Health Technology Assessment programme Eculizumab for treating atypical haemolytic uraemic syndrome
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced melanoma – second or third line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous administration of medications in home care settings: clinical evidence and guidelines
2014     Basque Office for Health Technology Assessment (OSTEBA) [The development and piloting of a multidisciplinary collaborative program for the comprehensive care of patients diagnosed with heart failure (HF) – PROMIC]
2014     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on intravenous therapy with temporary devices in adults]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation– negative advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: clinical and cost effectiveness
2014     Andalusian Health Technology Assessment Area (AETSA) [Guide to clinical practice of care in pregnancy and puerperium]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Ocriplasmin (Jetrea - Alcon Canada Inc.) indication: symptomatic vitreomacular adhesion
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation-positive advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness
2014     NIHR Health Technology Assessment programme Can rapid integrated Polymerase Chain Reaction (PCR)-based diagnostics for Gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Testing vitamin B12 levels in neuropathy, alopecia, dizziness, and fatigue: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab with ipilimumab for advanced melanoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Parent advisors in pediatric rehabilitation: clinical effectiveness and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) [Rapid review. Gender dysphoria. Diagnosis, treatment and health outcomes]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Preoperative consultation: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced or metastatic clear-cell renal cell carcinoma – second or third line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in transplant patients with chronic hepatitis c]
2014     NIHR Health Technology Assessment programme The clinical and cost effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2014     Health Quality Ontario (HQO) Preoperative cardiac stress tests for noncardiac surgery: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab (Cyramza) in combination with docetaxel for locally advanced or metastatic non-small cell lung cancer – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Linaclotide
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c waiting for liver transplant]
2014     NIHR Health Technology Assessment programme Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Health Quality Ontario (HQO) Preoperative resting echocardiography for noncardiac surgery: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab for metastatic colorectal cancer – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for sedation in the ICU or PICU: a review of cost-effectiveness and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c coinfected with human immunodeficiency virus]
2014     NIHR Health Technology Assessment programme Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Health Quality Ontario (HQO) Hemoglobin A1c testing in diabetes: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tasquinimod for chemotherapy naïve, metastatic hormone-relapsed prostate cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous blood reinfusion system for orthopedic surgery: clinical and cost-effectiveness
2014     Andalusian Health Technology Assessment Area (AETSA) [Selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Institute of Health Economics (IHE) Effectiveness of screening for endemic antibiotic resistant organisms (AROs) in hospital settings
2014     NIHR Horizon Scanning Centre (NIHR HSC) TH-302 in combination with doxorubicin for locally advanced or metastatic, unresectable soft tissue sarcoma – first line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for acute respiratory failure: a review of the clinical effectiveness and guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) [Updating of selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2014     NIHR Health Technology Assessment programme The effectiveness of collaborative care for people with memory problems in primary care: results of the CAREDEM case management modelling and feasibility study
2014     NIHR Horizon Scanning Centre (NIHR HSC) SpaceOAR® perirectal spacing system for prostate cancer radiation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Stem cell transplantation for biologic-resistant Crohn's disease
2014     NIHR Health Technology Assessment programme The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     NIHR Health Technology Assessment programme Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Macy catheter for rectal drug administration
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for cardiac failure: a review of the clinical effectiveness and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - clinical effectiveness and safety until 2 years after delivery, with economic evaluation
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Acupuncture - areas of application, current evidence and proven indications]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-operative cerebrospinal fluid removal: guidelines
2014     Andalusian Health Technology Assessment Area (AETSA) [Communication strategies with children and adolescents in the hospital or primary care setting]
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ablative techniques for the treatment of localised prostate cancer
2014     NIHR Health Technology Assessment programme The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy; effectiveness and safety until 2 years after delivery, with economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014     NIHR Horizon Scanning Centre (NIHR HSC) CoVa™ Monitoring System for congestive heart failure
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Opportunities and strategies to drive appropriate use of MRI in Austria
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Islet cell transplantation in patients with unstable diabetes: a review of clinical- and cost-effectiveness and guidelines